Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Mattar, Melina Andrade ^a   Gualano, Bruno ^a   Perandini, Luiz Augusto ^a   Shinjo, Samuel Katsuyuki ^a   Lima, Fernanda Rodrigues ^a   Sá Pinto, Ana Lúcia ^a   Roschel, Hamilton ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS SECTIONAL AREA; DERMATOMYOSITIS; EXERCISE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; KNEE FUNCTION; LEG; LONGITUDINAL STUDY; LOW INTENSITY RESISTANCE TRAINING; MALE; MUSCLE STRENGTH; MUSCULOSKELETAL SYSTEM PARAMETERS; ONE REPETITION MAXIMUM RESISTANCE TRAINING; PARTIAL BLOOD FLOW RESTRICTION TRAINING; POLYMYOSITIS; PROGRAM EFFECTIVENESS; PROSPECTIVE STUDY; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; QUASI EXPERIMENTAL STUDY; RESISTANCE TRAINING; SAFETY; SELF REPORT; SHORT FORM 36; VISUAL ANALOG SCALE; BLOOD FLOW VELOCITY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; TREATMENT OUTCOME; VASCULARIZATION;

ADULT; BLOOD FLOW VELOCITY; DERMATOMYOSITIS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; POLYMYOSITIS; PROSPECTIVE STUDIES; QUADRICEPS MUSCLE; QUALITY OF LIFE; RESISTANCE TRAINING; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 84988876814     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0473-5     Document Type: Article

References (36)

1. Hengstman GJ, van den Hoogen FH, van Engelen BG: Treatment of the inflammatory myopathies: update and practical recommendations. Expert Opin Pharmacother 2009, 10:1183-1190.
2. Alexanderson H, Broman L, Tollback A, Josefson A, Lundberg IE, Stenstrom CH: Functional index-2: validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. Arthritis Rheum 2006, 55:114-122.
3. Lundberg IE: Idiopathic inflammatory myopathies: why do the muscles become weak? Curr Opin Rheumatol 2001, 13:457-460.
4. Ponyi A, Borgulya G, Constantin T, Vancsa A, Gergely L, Danko K: Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford) 2005, 44:83-88.
5. Alexanderson H, Lundberg IE: Inflammatory muscle disease: clinical presentation and assessment of patients. Curr Rheumatol Rep 2007, 9:273-279.
6. Alexanderson H, Dastmalchi M, Esbjornsson-Liljedahl M, Opava CH, Lundberg IE: Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum 2007, 57:768-777.
7. Alexanderson H, Lundberg IE: Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies. Curr Opin Rheumatol 2012, 24:201-207.
8. Mattar MA, Gualano B, Roschel H, Perandini LA, Dassouki T, Lima FR, Shinjo SK, de Sa Pinto AL: Exercise as an adjuvant treatment in persistent active polymyositis. J Clin Rheumatol 2014, 20:11-15.
9. Spector SA, Lemmer JT, Koffman BM, Fleisher TA, Feuerstein IM, Hurley BF, Dalakas MC: Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve 1997, 20:1242-1248.
10. Alexanderson H, Stenstrom CH, Lundberg I: Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford) 1999, 38:608-611.
11. Alexanderson H, Stenstrom CH, Jenner G, Lundberg I: The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol 2000, 29:295-301.
12. Chung YL, Alexanderson H, Pipitone N, Morrison C, Dastmalchi M, Stahl-Hallengren C, Richards S, Thomas EL, Hamilton G, Bell JD, Lundberg IE, Scott DL: Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007, 57:694-702.
13. Dastmalchi M, Alexanderson H, Loell I, Stahlberg M, Borg K, Lundberg IE, Esbjornsson M: Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum 2007, 57:1303-1310.
14. Kraemer WJ, Ratamess NA: Fundamentals of resistance training: progression and exercise prescription. Med Sci Sports Exerc 2004, 36:674-688.
15. Abe T, Fujita S, Nakajima T, Sakamaki M, Ozaki H, Ogasawara R, Sugaya M, Kudo M, Kurano M, Yasuda T, Sato Y, Ohshima H, Mukai C, Ishii N: Effects of low-intensity cycle training with restricted leg blood flow on thigh muscle volume and VO2MAX in young men. J Sports Sci Med 2010, 9:452-458.
16. Karabulut M, Abe T, Sato Y, Bemben MG: The effects of low-intensity resistance training with vascular restriction on leg muscle strength in older men. Eur J Appl Physiol 2010, 108:147-155.
17. Laurentino GC, Ugrinowitsch C, Roschel H, Aoki MS, Soares AG, Neves M Jr, Aihara AY, da Rocha Correa Fernandes A, Tricoli V: Strength training with blood flow restriction diminishes myostatin gene expression. Med Sci Sports Exerc 2012, 44:406-412.
18. Takarada Y, Nakamura Y, Aruga S, Onda T, Miyazaki S, Ishii N: Rapid increase in plasma growth hormone after low-intensity resistance exercise with vascular occlusion. J Appl Physiol 2000, 88:61-65.
19. Takarada Y, Sato Y, Ishii N: Effects of resistance exercise combined with vascular occlusion on muscle function in athletes. Eur J Appl Physiol 2002, 86:308-314.
20. Takarada Y, Takazawa H, Sato Y, Takebayashi S, Tanaka Y, Ishii N: Effects of resistance exercise combined with moderate vascular occlusion on muscular function in humans. J Appl Physiol 2000, 88:2097-2106.
21. Gualano B, Neves M Jr, Lima FR, Pinto AL, Laurentino G, Borges C, Baptista L, Artioli GG, Aoki MS, Moriscot A, Lancha AH Jr, Bonfa E, Ugrinowitsch C: Resistance training with vascular occlusion in inclusion body myositis: a case study. Med Sci Sports Exerc 2010, 42:250-254.
22. Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292:403-407.
23. Gualano B, Ugrinowitsch C, Neves M Jr, Lima FR, Pinto AL, Laurentino G, Tricoli VA, Lancha AH Jr, Roschel H: Vascular occlusion training for inclusion body myositis: a novel therapeutic approach. J Vis Exp 2010, 40:1894.
24. Brown LE, Weir JP: ASEP procedures recommendation I: accurate assessmente of muscular strength and power. J Exerc Physiol Online 2001, 4:21.
25. Wasserman K, Whipp BJ, Koyl SN, Beaver WL: Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol 1973, 35:236-243.
26. Cohen J: Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale, USA: Lawrence Erlbaum Associates; 1988.
27. Varju C, Petho E, Kutas R, Czirjak L: The effect of physical exercise following acute disease exacerbation in patients with dermato/ polymyositis. Clin Rehabil 2003, 17:83-87.
28. Loenneke JP, Fahs CA, Wilson JM, Bemben MG: Blood flow restriction: the metabolite/volume threshold theory. Med Hypotheses 2011, 77:748-752.
29. Meyer RA: Does blood flow restriction enhance hypertrophic signaling in skeletal muscle? J Appl Physiol 2006, 100:1443-1444.
30. Abe T, Yasuda T, Midorikawa T, Sato Y, Kearns CF, Inoue K, Koizume K, Ishii N: Skeletal muscle size and circulating IGF-1 are increased after two weeks of twice daily "KAATSU" resistance training. Int J Kaatsu Training Res 2005, 1:6-12.
31. Takano H, Morita T, Iida H, Asada K, Kato M, Uno K, Hirose K, Matsumoto A, Takenaka K, Hirata Y, Eto F, Nagai R, Sato Y, Nakajima T: Hemodynamic and hormonal responses to a short-term low-intensity resistance exercise with the reduction of muscle blood flow. Eur J Appl Physiol 2005, 95:65-73.
32. Fry CS, Glynn EL, Drummond MJ, Timmerman KL, Fujita S, Abe T, Dhanani S, Volpi E, Rasmussen BB: Blood flow restriction exercise stimulates mTORC1 signaling and muscle protein synthesis in older men. J Appl Physiol 2010, 108:1199-1209.
33. Fujita S, Abe T, Drummond MJ, Cadenas JG, Dreyer HC, Sato Y, Volpi E, Rasmussen BB: Blood flow restriction during low-intensity resistance exercise increases S6K1 phosphorylation and muscle protein synthesis. J Appl Physiol 2007, 103:903-910.
34. Park JH, Olsen NJ, King L Jr, Vital T, Buse R, Kari S, Hernanz-Schulman M, Price RR: Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 1995, 38:68-77.
35. Cea G, Bendahan D, Manners D, Hilton-Jones D, Lodi R, Styles P, Taylor DJ: Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study. Brain 2002, 125:1635-1645.
36. Chung YL, Smith EC, Williams SC, Wassif WS, Salisbury JR, Simmons A, Howlett DC, Scott DL: In vivo proton magnetic resonance spectroscopy in polymyositis and dermatomyositis: a preliminary study. Eur J Med Res 1997, 2:483-487.